Skip to main content
This block is broken or missing. You may be missing content or you might need to enable the original module.
Home
  • English
  • Svenska
  • Français
  • Deutsch
  • Español
  • Italiano
  • Português

Main sub menu

  • Investerare
    • Investerare
    • Årsredovisning 2018
    • Erbjudande
    • Aktien
    • Finansiella nyheter
    • Finansiell översikt
    • Bolagsstyrning
  • Karriär
    • Arbeta på Recipharm
    • Historien om Recipharm
    • Träffa våra medarbetare
    • Lediga tjänster
  • Contact
    • Contact us
    • Development services contacts
    • Manufacturing services contacts
    • Locations
      • France
        • Fontaine
        • Kaysersberg
        • Monts
        • Pessac
      • Germany
        • Wasserburg
      • India
        • Bengaluru
        • Karnal / Paonta Sahib
      • Israel
        • Ness Ziona
      • Italy
        • Brescia
        • Lainate
        • Masate
        • Paderno Dugnano
      • Portugal
        • Odivelas
        • Queluz
      • Spain
        • Parets
        • Leganés
      • Sweden
        • Höganäs
        • Stockholm city (HQ)
        • Karlskoga
        • Solna
        • Stockholm
        • Strängnäs
        • Uppsala
        • Uppsala Development
      • UK
        • Holmes Chapel
        • Ashton
      • USA
        • Research Triangle Park

Main navigation

  • Development
    • Drug substance
    • Drug product
    • Analytical chemistry
    • Clinical trial material (CTM)
  • Manufacturing
    • Solids
    • Semi-solids
    • Liquids
    • Inhalation
    • Injectables
    • Ophthalmics
  • Solutions
    • Recipharm Analytical Solutions™
    • Recipharm Inhalation Solutions™
    • Recipharm Pathway to Clinic®
    • Serialisation
  • Learn
  • Press & events
    • Press
    • Events
    • Reports
    • Insights
  • Our story
    • Recipharm in brief
    • Business model
    • Business overview
    • Sustainability
    • Company history

Investor relations

Finansiella nyheter

Financial information

  • Finansiella pressmeddelanden
  • Finansiella events
  • Finansiella rapporter
Displaying 1 - 10 of 28

Financial Report

Recipharm AB publicerar delårsrapport januari - september 2019

2019.11.07 Read more

Financial Report

Recipharm AB publicerar delårsrapport januari - juni 2019

2019.07.25 Read more

Financial Report

Recipharm AB publicerar delårsrapport januari - mars 2019

2019.05.03 Read more

Financial Report

Recipharm publicerar Årsredovisning 2018

2019.04.17 Read more

Financial Report

Recipharm AB publicerar bokslutskommuniké 2018

2019.02.21 Read more

Financial Report

Recipharm AB publicerar delårsrapport januari - september 2018

2018.11.08 Read more

Financial Report

Recipharm AB publicerar delårsrapport januari - juni 2018

2018.07.25 Read more

Financial Report

Recipharm AB publicerar delårsrapport januari-mars 2018

2018.04.27 Read more

Financial Report

Recipharm publicerar Årsredovisning 2017

2018.04.23 Read more

Financial Report

Recipharm AB publicerar bokslutskommuniké för 2017

2018.02.22 Read more

Pagination

  • Current page 1
  • Sida 2
  • Sida 3
  • Next page Next ›
  • Last page Last »

Investerare

  • Investerare
  • Årsredovisning 2018
  • Erbjudande
  • Aktien
  • Finansiella nyheter
  • Finansiell översikt
  • Bolagsstyrning
Kontakt

Kontakta oss

ir@recipharm.com
+46 8 602 52 00

Prenumerera

Footer menu

  • Privacy policy
  • Cookies
  • Website terms
  • T&C of sale and delivery
© 2019 Recipharm AB (publ). All rights reserved Stormfors Digitalbyrå